KEROS THERAPEUTICS INC

Ticker: KROS CUSIP: 492327101 Class: Common Stock

D. E. Shaw & Co., Inc.'s Holding History (CIK: 0001009207)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 755,473 Value ($000) $15,381 Avg Close $17.54 Range $13.60 - $22.55
Q3 2025
Shares 1,331,425 Value ($000) $21,063 Avg Close $14.77 Range $13.13 - $16.30
Q2 2025
Shares 1,297,383 Value ($000) $17,320 Avg Close $13.50 Range $9.12 - $15.40
Q1 2025
Shares 1,263,130 Value ($000) $12,871 Avg Close $11.61 Range $9.71 - $16.70
Q4 2024
Shares 12,099 Value ($000) $192 Avg Close $51.97 Range $15.33 - $72.37
Q3 2024
Shares 186,288 Value ($000) $10,818 Avg Close $49.39 Range $40.93 - $59.06
Q2 2024
Shares 175,695 Value ($000) $8,029 Avg Close $53.73 Range $43.30 - $67.30
Q1 2024
Shares 18,874 Value ($000) $1,249 Avg Close $59.30 Range $39.00 - $73.00
Q1 2023
Shares 31,032 Value ($000) $1,325 Avg Close $50.51 Range $39.98 - $59.96
Q2 2022
Shares 21,056 Value ($000) $582 Avg Close $43.88 Range $24.38 - $68.29
Q1 2021
Shares 26,142 Value ($000) $1,609 Avg Close $63.36 Range $51.48 - $75.99
Q4 2020
Shares 55,202 Value ($000) $3,894 Avg Close $63.02 Range $34.17 - $88.80